Target: RNase L
Clone: 2E9
Purification method: This monoclonal antibody was purified using Protein A
Immunogen: Purified, full-length, recombinant, human RNaseL produced in insect cells.
Concentration: ≥ 2.0 mg/ml
Formulation: This antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Purity: >95% by SDS-PAGE and HPLC
Endotoxin: ≤ 1.0 EU/mg as determined by the LAL method
Aggregation: Aggregation level ≤ 5%
Use: Products are for research use only. Not for use in diagnostic or therapeutic procedures.